4129 Stock Overview
United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical instruments.
United Orthopedic Corporation Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||NT$29.90|
|52 Week High||NT$32.70|
|52 Week Low||NT$27.50|
|1 Month Change||2.05%|
|3 Month Change||6.60%|
|1 Year Change||-6.71%|
|3 Year Change||-33.78%|
|5 Year Change||-55.90%|
|Change since IPO||112.06%|
Recent News & Updates
|4129||TW Medical Equipment||TW Market|
Return vs Industry: 4129 underperformed the TW Medical Equipment industry which returned -3.6% over the past year.
Return vs Market: 4129 exceeded the TW Market which returned -11% over the past year.
|4129 Average Weekly Movement||2.9%|
|Medical Equipment Industry Average Movement||5.1%|
|Market Average Movement||5.0%|
|10% most volatile stocks in TW Market||8.3%|
|10% least volatile stocks in TW Market||2.5%|
Stable Share Price: 4129 is less volatile than 75% of TW stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: 4129's weekly volatility (3%) has been stable over the past year.
About the Company
United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical instruments. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fracture, Moore hip prosthesis, and customized artificial hip joints for individual tumor patients; artificial knee joint, such as artificial knee replacement joint, revision knee replacement system, restricted artificial knee joints, and customized artificial knee joints for individual tumor patients; and spine products consisting of vertebral fixation devices. It also provides injury and other orthopedic products comprise orthopedic internal fixation, bone plates, bone nails, bone pins, and bone screws; OEM products, such as orthopedic internal fixation; and lamb salvage systems.
United Orthopedic Corporation Fundamentals Summary
|4129 fundamental statistics|
Is 4129 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|4129 income statement (TTM)|
|Cost of Revenue||NT$749.05m|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||0.90|
|Net Profit Margin||2.62%|
How did 4129 perform over the long term?See historical performance and comparison